Pathophysiology of muscle dysfunction in COPD

Journal of Applied Physiology

Volumn 114, Issue 9, 2013, Pages 1222-1234

  Gea, Joaquim ^a,b   Agustí, Alvar ^b,c,d   Roca, Josep ^b,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Fundació Investigació Sanitària Illes Balears FISIB   (Spain)

Author keywords

Deconditioning; Exacerbations; Exercise; Hyperinflation; Limb muscles; Muscle dysfunction; Muscle wasting; Respiratory muscles

Indexed keywords

BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DECONDITIONING; EXACERBATIONS; EXERCISE; FEMALE; HUMAN; HYPERINFLATION; LIMB MUSCLES; MALE; MUSCLE ATROPHY; MUSCLE DYSFUNCTION; MUSCLE FATIGUE; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

DECONDITIONING; EXACERBATIONS; EXERCISE; HYPERINFLATION; LIMB MUSCLES; MUSCLE DYSFUNCTION; MUSCLE WASTING; RESPIRATORY MUSCLES;

FEMALE; HUMANS; MALE; MUSCLE FATIGUE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES;

EID: 84878563618     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00981.2012     Document Type: Review

References (213)

1. Abdellaoui A, Préfaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J 38:781-788, 2011.
2. Aguar MC, Gea J, Aran X, Guiu R, Orozco-Levi M, Broquetas JM. Modifications in the mechanical activity of the diaphragm induced by the inhalation of CO2 in patients with chronic obstructive pulmonary disease. Arch Bronconeumol 29:226-228, 1993.
3. Agustí AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:485-489, 2002.
4. Agustí A, Morlá M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59:483-487, 2004. (Pubitemid 38797520)
5. American Thoracic Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159:S1-S40, 1999.
6. Ansari K, Keaney N, Taylor I, Burns G, Farrow M. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J 88:372-376, 2012.
7. Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn JA, Yasuhara SE. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One 2:e806, 2007.
8. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 155:549-554, 1997. (Pubitemid 27085800)
9. Balcells E, Antó JM, Gea J, Gómez FP, Rodríguez E, Marin A, Ferrer A, De Batlle J, Farrero E, Benet M, Orozco-Levi M, Ferrer J, Agustí AG, Gáldiz JB, Belda J, Garcia-Aymerich J; Study Group PACCOPD. Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 103:1293-1302, 2009.
10. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29:771-778, 2003. (Pubitemid 38045945)
11. Barreiro E, De La Puente B, Minguella J, Corominas JM, Serrano S, Hussain S, Gea J. Oxidative stress and respiratory muscle dysfunction in severe COPD. Am J Respir Crit Care Med 171:1116-1124, 2005. (Pubitemid 40663723)
12. Barreiro E, Rabinovich R, Marin-Corral J, Barberà JA, Gea J, Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64:13-19, 2009.
13. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sánchez F, Gea J, Barberà JA; in COPD Project ENIGMA. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182:477-488, 2010.
14. Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J, Lloreta J, Gea J. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111:808-817, 2011.
15. Barreiro E, Sznajder JI. Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction. J Appl Physiol. (Published ahead of print January 10, 2013). doi:10.1152/japplphysiol.01027. 2012.
16. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:629-634, 1998. (Pubitemid 28378196)
17. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 29:197-206, 1997. (Pubitemid 27113514)
18. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, De Chiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708, 2001. (Pubitemid 33104839)
19. Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sánchez-Font A, Garcia-Aymerich J, Coronell C, Lloreta J, Agusti AG, Gea J, Howington JA, Reed MF, Starnes SL, Harris NL, Vitucci M, Eppert BL, Motz GT, Fogel K, McGraw DW, Tichelaar JW, Orozco-Levi M. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest 119:636-649, 2009.
20. Bossenbroek L, De Greef MH, Wempe JB, Krijnen WP, Ten Hacken NH. Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD 8:306-319, 2011.
21. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 81:3469-3475, 1996. (Pubitemid 26339901)
22. Brunelle JK, Chandel NS. Oxygen deprivation induced cell death: an update. Apoptosis 7:475-482, 2002. (Pubitemid 35334441)
23. Burdet L, De Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 156:1800-1806, 1997. (Pubitemid 28011785)
24. Casadevall C, Coronell C, Ramírez-Sarmiento AL, Martínez-Llorens J, Barreiro E, Orozco-Levi M, Gea J. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 30:701-707, 2007. (Pubitemid 351194830)
25. Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 5:CD002309, 2011.
26. Chopard A, Hillock S, Jasmin BJ. Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures. J Cell Mol Med 13:3032-3050, 2009.
27. Convertino VA, Bloomfield SA, Greenleaf JE. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc 29:187-190, 1997. (Pubitemid 27113512)
28. Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24:129-136, 2004. (Pubitemid 39029078)
29. Corwin EJ, Klein LC, Rickelman K. Predictors of fatigue in healthy young adults: moderating effects of cigarette smoking and gender. Biol Res Nurs 3:222-233, 2002.
30. Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 20:1123-1129, 2002. (Pubitemid 35331868)
31. Couillard A, Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, Le Blanc P, Préfaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1664-1669, 2003. (Pubitemid 36760681)
32. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1239-1245, 2000.
33. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:76s-80s, 2003. (Pubitemid 37351739)
34. Crul T, Testelmans D, Spruit MA, Troosters T, Gosselink R, Geeraerts I, Decramer M, Gayan-Ramirez G. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem 25:491-500, 2010.
35. Davis MP. The emerging role of palliative medicine in the treatment of lung cancer patients. Cleve Clin J Med 79, Electronic Suppl 1:eS51-eS55, 2012.
36. Debigaré R, Côté CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 164:1712-1717, 2001. (Pubitemid 33124163)
37. Debigaré R, Marquis K, Côté CH, Tremblay RR, Michaud A, Le Blanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124:83-89, 2003. (Pubitemid 36851335)
38. Debigaré R, Côté CH, Maltais F. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 7:84-90, 2010.
39. Decramer M, De Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153:1958-1964, 1996. (Pubitemid 26187926)
40. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 10:417-423, 1997. (Pubitemid 27063862)
41. De Troyer A, Sampson M, Sigrist S, Macklem PT. The diaphragm: two muscles. Science 213:237-238, 1981. (Pubitemid 11060576)
42. De Troyer A. The electro-mechanical response of canine inspiratory intercostal muscles to increased resistance: the caudal rib-cage. J Physiol 451:463-476, 1992.
43. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455, 1994. (Pubitemid 24356667)
44. Di Marco AF, Romaniuk JR, Supinski GS. Parasternal and external intercostal responses to various respiratory maneuvers. J Appl Physiol 73:979-986, 1992.
45. Doucet M, Debigare R, Joanisse DR, Cote C, Leblanc P, Gregoire J, Deslauriers J, Vaillancourt R, Maltais F. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J 24:971-979, 2004. (Pubitemid 39642288)
46. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, Caron MA, Le Blanc P, Maltais F. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:261-269, 2007. (Pubitemid 47195876)
47. Eisner MD, Iribarren C, Blanc PD, Yelin EH, Ackerson L, Byl N, Omachi TA, Sidney S, Katz PP. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax 66:108-114, 2011.
48. Engelen MP, Deutz NE, Wouters EF, Schols AM. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1488-1492, 2000.
49. Engelen MP, Schols AM, Does JD, Gosker HR, Deutz NE, Wouters EF. Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1697-1704, 2000.
50. Engelen MP, Wouters EF, Deutz NE, Menheere PP, Schols AM. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 72:1480-1487, 2000.
51. Engelen MP, Wouters EF, Deutz NE, Does JD, Schols AM. Effects of exercise in amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:859-864, 2001. (Pubitemid 32275855)
52. England BK, Chastain JL, Mitch WE. Abnormalities in protein synthesis and degradation induced by extracellular pH in BC3H1 myocytes. Am J Physiol Cell Physiol 260:C277-C282, 1991.
53. Epstein SK. An overview of respiratory muscle function. Clin Chest Med 15:619-639, 1994. (Pubitemid 24371951)
54. Estívariz CF, Ziegler TR. Nutrition and the insulin-like growth factor system. Endocrine 7:65-71, 1997. (Pubitemid 127483089)
55. Fermoselle C, Rabinovich R, Ausín P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J 40:851-862, 2012.
56. Franssen FM, Sauerwein HP, Rutten EP, Wouters EF, Schols AM. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur Respir J 32:1466-1471, 2008.
57. Franssen FM, Sauerwein HP, Ackermans MT, Rutten EP, Wouters EF, Schols AM. Increased postabsorptive and exercise-induced wholebody glucose production in patients with chronic obstructive pulmonary disease. Metabolism 60:957-964, 2011.
58. Gan WQ, Man WQ, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574-580, 2004. (Pubitemid 38901515)
59. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61:772-778, 2006. (Pubitemid 44369401)
60. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a populationbased cohort study. Am J Respir Crit Care Med 175:458-63, 2007. (Pubitemid 46354249)
61. Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, De Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí AG, Antó JM; and Course of COPD Study Group. Phenotype, physical activity, and clinical and functional status in COPD. Chest 136:62-70, 2009.
62. Gass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int Biochem Cell Biol 37:1974-1984, 2005.
63. Gea J, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17:939-945, 2001. (Pubitemid 32600343)
64. Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. Monaldi Arch Chest Dis 56:214-224, 2001. (Pubitemid 32951962)
65. Gea J, Barreiro E, Orozco-Levi M. Free radicals, cytokines and respiratory muscles in COPD patients. Clin Pulm Med 14:117-126, 2007. (Pubitemid 46763347)
66. Gea J, Casadevall C, Pascual S, Orozco-Levi M, Barreiro E. Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 6:75-90, 2012.
67. Gonzalez NC, Wood JG. Alveolar hypoxia-induced systemic inflammation: what low PO2 does and does not do. Adv Exp Med Biol 662:27-32, 2010.
68. Gosker HR, Engelen MP, Van Mameren H, Van Dijk PJ, Van Der Vusse GJ, Wouters EF, Schols AM. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76:113-119, 2002. (Pubitemid 34686556)
69. Gosker HR, Van Mameren H, Van Dijk PJ, Engelen MP, Van Der Vusse GJ, Wouters EF, Schols AM. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19:617-625, 2002. (Pubitemid 34285157)
70. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30:73-79, 2007. (Pubitemid 47074009)
71. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62:944-949, 2007. (Pubitemid 350084491)
72. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976-980, 1996. (Pubitemid 26081648)
73. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 152:2021-2031, 1995.
74. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35:719-729, 2003. (Pubitemid 36773583)
75. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 351:2112-2114, 2004. (Pubitemid 39482505)
76. Hernández N, Orozco-Levi M, Belalcázar V, Pastó M, Minguella J, Broquetas JM, Gea J. Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 134:219-229, 2003. (Pubitemid 36349245)
77. Heunks LM, Viña J, Van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol 277:R1697-R1704, 1999. (Pubitemid 30043777)
78. Hofford JM, Milakofsky L, Vogel WH, Sacher RS, Savage GJ, Pell S. The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels. Am Rev Respir Dis 141:902-908, 1990. (Pubitemid 20157717)
79. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8:25, 2007.
80. Hoppeler H, Desplanches D. Muscle structural modifications in hypoxia. Int J Sports Med 13, Suppl 1:S166-S168, 1992.
81. Hussain SN, Sandri M. Role of autophagy in COPD skeletal muscle dysfunction. J Appl Physiol (Published ahead of print October 18, 2012). doi:10.1152/japplphysiol.00893.2012.
82. Jagoe RT, Engelen MP. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:52s-63s, 2003. (Pubitemid 37351737)
83. Jakobsson P, Jordfelt L, Henriksson. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151:374-377, 1995.
84. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 3:192-196, 1996.
85. Jimenez M, Gea J, Aguar MC, Minguella J, Lloreta J, Félez M, Broquetas J. Capillary density and respiratory function in the external intercostal muscle. Arch Bronconeumol 35:471-476, 1999.
86. Jobin J, Maltais F, Doyon JF, Le Blanc P, Simard PM, Simard AA, Simard C. Chronic obstructive pulmonary disease: capillarity and fibertype characteristics of skeletal muscle. J Cardiopulm Rehabil Prev 18:432-437, 1998. (Pubitemid 29024891)
87. Jones DA. Skeletal muscle physiology: structure, biomechanics, and biochemistry. In: The Thorax Part A: Physiology, edited by Roussos Ch. New York: Dekker, 1995, p 3-32.
88. Kaiser P, Hylander B, Eliasson K, Kaijer L. Effect of beta1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension. Am J Cardiol 55:79D-84D, 1985. (Pubitemid 15099998)
89. Kaminski HJ, Ruff RL. Endocrine myopathies (hyper-and hypofunction of adrenal, thyroid, pituitary, and parathyroid glands), and iatrogenic corticosteroid myopathy. In: Myology, edited by Engel AG, Franzini-Armstrong C. New York: McGraw-Hill, 1994, p. 1726-1733.
90. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 186:403-409, 2008.
91. Karadag F, Ozcan H, Karul AB, Yilmaz M, Cildag O. Sex hormone alterations and systemic inflammation in chronic obstructive pulmonary disease. Int J Clin Pract 63:275-281, 2009.
92. Karatas GK, Günedi Z. Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation. Neurorehabilitation 27:141-145, 2010.
93. Keim NL, Luby MH, Braun SR, Martin AM, Dixon RM. Dietary evaluation of outpatients with chronic obstructive pulmonary disease. J Am Diet Assoc 86:902-906, 1986. (Pubitemid 16060867)
94. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 6:199-208, 2011.
95. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis 146:935-940, 1992.
96. King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:519-523, 2008. (Pubitemid 351669180)
97. Koda-Kimble MA, Young LY, Alldredge BK, Corelli RL, Guglielmo BJ, Kradjan WA, Williemas BR. Applied Therapeutics (IX ed.). Philadelphia, PA: Lippincott Williams & Wilkins, 2009.
98. Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 169:1022-1027, 2004. (Pubitemid 38543641)
99. Kulisz A, Chen N, Chandel NS, Shao Z, Schumacker PT. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol 282:L1324-L1329, 2002. (Pubitemid 34654589)
100. Laghi F, Langbein WE, Antonescu-Turcu A, Jubran A, Bammert C, Tobin MJ. Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:598-605, 2005. (Pubitemid 40365415)
101. Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Am J Physiol Regul Integr Comp Physiol 300:R1142-R1147, 2011.
102. Layec G, Haseler LJ, Richardson RS. The effect of higher ATP cost of contraction on the metabolic response to graded exercise in patients with chronic obstructive pulmonary disease. J Appl Physiol 112:1041-1048, 2012.
103. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337:1799-1806, 1997. (Pubitemid 28006784)
104. Levine S, Nguyen T, Friscia M, Zhu J, Szeto W, Tikunov BA, Rubinstein NA, Kaiser LR, Shrager JB. Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. J Appl Physiol 101:1297-1302, 2006.
105. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J, Hopkinson NS, Polkey MI, Kemp PR. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 67:26-34, 2012.
106. Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, Bendavid E, Saynina O, Salpeter SR, Garber AM, Hoffman AR. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med 148:747-758, 2008. (Pubitemid 351717421)
107. Lieu F, Powers SK, Herb RA, Criswell D, Martin D, Wood C, Stainsby W, Chen CL. Exercise and glucocorticoid-induced diaphragmatic myopathy. J Appl Physiol 75:763-771, 1993. (Pubitemid 23260219)
108. Liu Q, Xu WG, Luo Y, Han FF, Yao XH, Yang TY, Zhang Y, Pi WF, Guo XJ. Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs. J Cell Biochem 112:2307-2316, 2011.
109. Lloreta J, Orozco-Levi M, Gea J, Broquetas J. Selective diaphragmatic mitochondrial abnormalities in a patient with marked airflow obstruction. Ultrastruct Pathol 20:67-71, 1996. (Pubitemid 26049971)
110. Macklem PT, Gross D, Grassino GA, Roussos C. Partitioning of inspiratory pressure swings between diaphragm and intercostal/accessory muscles. J Appl Physiol 44:200-208, 1978. (Pubitemid 9137195)
111. Macklem PT. Exercise in COPD: damned if you do and damned if you don't. Thorax 60:887-888, 2005. (Pubitemid 41598200)
112. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2:216-224, 2001. (Pubitemid 34187929)
113. Mahajan H, Richards SM, Rattigan S, Clark MG. T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulinmediated muscle hemodynamic effects and glucose uptake in vivo. Br J Pharmacol 140:1283-1291, 2003. (Pubitemid 38117433)
114. Maltais F, Leblanc P, Simard C, Jobin J, Berubé C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:442-447, 1996. (Pubitemid 26269117)
115. Maltais F, Le Blanc P, Whittom F, Simard C, Marquis K, Bélanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55:848-853, 2000.
116. Man WD, Moxham J, Polkey MI. Magnetic stimulation for the measurement of respiratory and skeletal muscle function. Eur Respir J 24:846-860, 2004. (Pubitemid 39504441)
117. Mangueira NM, Viega IL, Mangueira Mde A, Pinheiro AN, Costa Mdo R. Correlation between clinical parameters and health-related quality of life in women with COPD. J Bras Pneumol 35:248-255, 2009.
118. Marin-Corral J, Minguella J, Ramírez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 33:1309-1319, 2009.
119. Martínez-Llorens J, Coronell C, Ramírez-Sarmiento A, Orozco-Levi M, Espadaler JM, Bautista Gáldiz J, Gea J. Determination of maximal diaphragm strength in chronic obstructive pulmonary disease: cervical magnetic stimulation versus traditional sniff maneuver. Arch Bronconeumol 42:509-515, 2006. (Pubitemid 44759293)
120. Mathur S, Takai KP, Macintyre DL, Reid D. Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease. Phys Ther 88:219-30, 2008. (Pubitemid 351196715)
121. McKenzie DK, Butler JE, Gandevia SC. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 107:621-629, 2009.
122. McParland C, Resch EF, Krishnan B, Wang Y, Cujec B, Gallagher CG. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 151:1101-1107, 1995.
123. Menon MK, Houchen L, Singh SJ, Morgan MD, Bradding P, Steiner MC. Inflammatory and satellite cells in the quadriceps of patients with COPD and the response to resistance training. Chest 142:1134-1142, 2012.
124. Mercken EM, Hageman GJ, Langen RC, Wouters EF, Schols AM. Decreased exercise-induced expression of nuclear factor-κB-regulated genes in muscle of patients with COPD. Chest 139:337-346, 2011.
125. Montes De Oca M, Torres SH, De Sanctis J, Mata A, Hernández N, Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26:390-397, 2005. (Pubitemid 41264199)
126. Morla M, Iglesias A, Sauleda J, Cosio B, Agustí A, Busquets X. Reduced expression of the sarcoplasmic calcium pump SERCA2 in skeletal muscle from patients with chronic obstructive pulmonary disease and low body weight. Arch Bronconeumol 43:4-8, 2007. (Pubitemid 46232750)
127. Morley JE. Sarcopenia in the elderly. Fam Pract 29, Suppl 1:i44-i48, 2012.
128. Morrison WL, Gibson JN, Scrimgeour C, Rennie MJ. Muscle wasting in emphysema. Clin Sci (Lond) 75:415-420, 1988.
129. Morse CI, Wüst RC, Jones DA, De Haan A, Degens H. Muscle fatigue resistance during stimulated contractions is reduced in young male smokers. Acta Physiol (Oxf) 191:123-129, 2007. (Pubitemid 47390298)
130. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94:859-867, 2000.
131. Nader GA. Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int J Biochem Cell Biol 37:1985-1996, 2005. (Pubitemid 41206816)
132. Naimi AI, Bourbeau J, Perrault H, Baril J, Wright-Paradis C, Rossi A, Taivassalo T, Sheel AW, Rabøl R, Dela F, Boushel R. Altered mitochondrial regulation in quadriceps muscles of patients with COPD. Clin Physiol Funct Imaging 31:124-131, 2011.
133. O'Shea SD, Taylor NF, Paratz JD. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest 136:1269-1283, 2009.
134. Orozco-Levi M, Gea J, Lloreta J, Félez M, Minguella J, Serrano S, Broquetas JM. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 13:371-378, 1999. (Pubitemid 29086836)
135. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas J, Gea J. Injury of the human diaphragm associated with exertion and COPD. Am J Respir Crit Care Med 164:1734-1739, 2001.
136. Orozco-Levi M, Coronell C, Ramírez-Sarmiento A, Lloreta J, Martínez-Llorens JM, Gáldiz JB, Gea J. Injury of peripheral muscles in smokers with chronic obstructive pulmonary disease. Ultrastruct Pathol 36:228-238, 2012.
137. Pepin V, Saey D, Laviolette L, Maltais F. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 4:195-204, 2007. (Pubitemid 47345896)
138. Petersen AM, Magkos F, Atherton P, Selby A, Smith K, Rennie MJ, Pedersen BK, Mittendorfer B. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab 293:E843-E848, 2007. (Pubitemid 47358998)
139. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 96:594.598, 2002.
140. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 129:536.544, 2006.
141. Plant PJ, Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, Pearce D, Binnie M, Batt J. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 42:461.471, 2010.
142. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med 6:190.196, 2006.
143. Porter GA, Makuck RF, Rivkees SA. Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem 277:28942-28947, 2002.
144. Pouw EM, Schols AM, Deutz NE, Wouters EF. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:797.801, 1998.
145. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Torres A,
146. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Gonzalez-Aragoneses F, Bravo JL, Alvarez FV, Camano S, Agusti A. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J 33:1045.1052, 2009.
147. Puente-Maestu L, Lazaro A, Tejedor A, Camano S, Fuentes M, Cuervo M, Navarro BO, Agusti A. Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 66:121.127, 2011.
148. Puente-Maestu L, Tejedor A, Lazaro A, De Miguel J, Alvarez-Sala L, Gonzalez-Aragoneses F, Simon C, Agusti A. Site of mitochondrial ROS production in skeletal muscle of COPD and its relationship with exercise oxidative stress. Am J Respir Cell Mol Biol 47:358.362, 2012.
149. Qiu Z, Zhao D, Shi Y, Liu Y. The effects of high dose atropine on function of isolated diaphragmatic preparation of rats with omethoate poisoning. Zhonghua Nei Ke Za Zhi 40:187.189, 2001.
150. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez De Suso JM, Vilaro J, Barberà JA, Polo MF, Argiles JM, Fernandez-Checa JC, Roca J. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1114.1118, 2001.
151. Rabinovich RA, Ardite E, Mayer AM, Polo MF, Vilaro J, Argiles JM, Roca J. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 73:757.761, 2006.
152. Rafferty GF, Lou Harris M, Polkey MI, Greenough A, Moxham J. Effect of hypercapnia on maximal voluntary ventilation and diaphragm fatigue in normal humans. Am J Respir Crit Care Med 160:1567.1571, 1999.
153. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 1:291.315, 2002.
154. Ramirez-Sarmiento A, Orozco-Levi M, Barreiro E, Mendez R, Ferrer A, Broquetas J, Gea J. Expiratory muscle endurance in chronic obstructive pulmonary disease. Thorax 57:132.136, 2002.
155. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, Barreiro E, Hernandez N, Mota S, Sangenis M, Broquetas JM, Casan P, Gea J. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 166:1491.1497, 2002.
156. Ramirez-Sarmiento A, Pascual S, Martinez-Llorens JM, Gea J, Orozco-Levi M. Inspiratory muscle strength predicts mortality in patients with chronic obstructive pulmonary disease (Abstract). Eur Respir J 36, Suppl: 611s, 2010.
157. Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 52:387.398, 1993.
158. Rehn TA, Munkvik M, Lunde PK, Sjaastad I, Sejersted OM. Intrinsic skeletal muscle alterations in chronic heart failure patients: a diseasespecific myopathy or a result of deconditioning? Heart Fail Rev 17:421.436, 2012.
159. Reid MB, Lannergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166:479.484, 2002.
160. Reynolds TH 4th, Bodine SC, Lawrence JC Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 277:17657.17662, 2002.
161. Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:873.879, 2003.
162. 2 with small muscle mass exercise. Am J Respir Crit Care Med 169:89.96, 2004.
163. Rochester DF, Braun NMT, Arora NS. Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis 119:151.154, 1979.
164. Rochester DF, Braun NM. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 132:42.47, 1985.
165. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med 52:88.94, 2012.
166. Rodriguez DA, Alcarraz-Vizan G, Diaz-Moralli S, Reed M, Gomez FP, Falciani F, Gunther U, Roca J, Cascante M. Plasma metabolic profile in COPD patients: effects of exercise and endurance training. Metabolomics 8:508.516, 2012.
167. Roig M, Eng JJ, MacIntyre DL, Road JD, Reid WD. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 31:120.124, 2011.
168. Saey D, Ribeiro F. Resistance training preserves skeletal muscle function in patients with COPD who are hospitalised with an acute exacerbation. J Physiother 57:194, 2011.
169. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, Barberà JA, Nadal J, De Jover L, Rodriguez-Roisin R, Wagner PD. Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1726.1734, 1999.
170. Sanchez J, Brunet A, Medrano G, Debesse B, Derenne JP. Metabolic enzymatic activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease. Eur Respir J 1:376.383, 1988.
171. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399.412, 2004.
172. Satta A, Migliori GB, Spanevello A, Neri M, Bottinelli R, Canepari M, Pellegrino MA, Reggiani C. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 10:2853.2860, 1997.
173. Sauleda J, Garcia-Palmer F, Wiesner RJ, Tarraga S, Harting I, Tomas P, Gomez C, Saus C, Palou A, Agusti AG. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1413.1417, 1998.
174. Scalvini S, Volterrani M, Vitacca M, Clark AL, Solfrini R, Panzali AM, Ferrari R, Levi GF. Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Arch Chest Dis 51:380.386, 1996.
175. Schols AM, Soeters PB, Mostert R, Saris WH, Wouters EF. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis 143:1248.1252, 1991.
176. Schols AMWJ, Soeters PB, Dingemans MC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am J Respir Crit Care Med 147:1151.1156, 1993.
177. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, Wouters EF. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 36:81.88, 2010.
178. Shiota S, Okada T, Naitoh H, Ochi R, Fukuchi Y. Hypoxia and hypercapnia affect contractile and histological properties of rat diaphragm and hind limb muscles. Pathophysiology 11:23-30, 2004. (Pubitemid 38721309)
179. Simard C, Maltais F, Leblanc P, Simard PM, Jobin J. Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study. Med Sci Sports Exerc 28:S95, 1996.
180. Similowsky Th, Yan S, Gaithier AP, Macklem PT. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 325:917-923, 1991.
181. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of "overspill" of inflammatory mediators from the lungs? Review of the evidence. Thorax 65:930-936, 2010.
182. Singel DJ, Stamler JS. Blood traffic control. Nature 430:297, 2004. (Pubitemid 38937723)
183. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58:752-756, 2003. (Pubitemid 37094049)
184. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403, 2004. (Pubitemid 38591410)
185. Subramanian HH, Holstege G. Midbrain and medullary control of postinspiratory activity of the crural and costal diaphragm in vivo. J Neurophysiol 105:2852-2862, 2011.
186. Sun Z, Liu L, Liu N, Liu Y. Muscular response and adaptation to diabetes mellitus. Front Biosci 13:4765-4794, 2008. (Pubitemid 351589196)
187. Sundar IK, Yao H, Rahman I. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal 2012 Nov. 6. [Epub ahead of print].
188. Supinski G. Free radical-induced respiratory muscle dysfunction. Mol Cell Biochem 179:99-110, 1998. (Pubitemid 28118845)
189. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62:115-120, 2007.
190. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:1179-1184, 2000. (Pubitemid 30243827)
191. Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 35:549-56, 2010.
192. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:1072-1077, 2010.
193. Turan N, Kalko S, Stincone A, Clarke K, Sabah A, Howlett K, Curnow SJ, Rodriguez DA, Cascante M, O'Neill L, Egginton S, Roca J, Falciani F. A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol 7:e1002129, 2011.
194. Van Den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, Schols AM, Gosker HR. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-tomoderate COPD. J Appl Physiol (Published ahead of print July 19, 2012). doi:10.1152/japplphysiol.00508.2012.
195. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380:297-309, 2004. (Pubitemid 38788101)
196. Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38:1543-1552, 2006. (Pubitemid 44373772)
197. Van't Hul A, Harlaar J, Gosselink R, Hollander P, Postmus P, Kwakkel G. Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 29:267-274, 2004. (Pubitemid 38166850)
198. Vermeeren MA, Schols AM, Wouters EF. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J 10:2264-2269, 1997. (Pubitemid 27479547)
199. Vermeeren MAP, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF; Study Group COSMIC. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 100:1349-1355, 2006. (Pubitemid 43942332)
200. Vestbo J, Prescott E, Almadal T, Dahl M, Nodestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173:79-83, 2006. (Pubitemid 43069791)
201. Vilaró J, Ramirez-Sarmiento A, Martínez-Llorens JM, Mendoza T, Alvarez M, Sánchez-Cayado N, Vega A, Gimeno E, Coronell C, Gea J, Roca J, Orozco-Levi M. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 104:1896-1902, 2010.
202. Vogiatzis I, Habazettl H, Aliverti A, Athanasopoulos D, Louvaris Z, Lo Mauro A, Wagner H, Roussos C, Wagner PD, Zakynthinos S. Effect of helium breathing on intercostal and quadriceps muscle blood flow during exercise in COPD patients. Am J Physiol Regul Integr Comp Physiol 300:R1549-R1559, 2011.
203. Waclawik AJ, Sufit RL, Beinlich BR, Schutta HS. Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord 2:19-26, 1992.
204. Whittom F, Jobin J, Simard PM, Le Blanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 30:1467-1474, 1998. (Pubitemid 28465510)
205. Wijnhoven JH, Janssen AJ, Van Kuppevelt TH, Rodenburg RJ, Dekhuijzen PN. Metabolic capacity of the diaphragm in patients with COPD. Respir Med 100:1064-1071, 2006.
206. Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 39:535-538, 1984. (Pubitemid 14122885)
207. Wilson DO, Rogers RM, Hoffman RM. Nutrition and chronic lung disease. Am Rev Respir Dis 132:1347-1365, 1985. (Pubitemid 16156397)
208. Wüst RC, Morse CI, De Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 104:103-110, 2008.
209. Yang L, Zhou M, Smith M, Yang G, Peto R, Wang J, Boreham J, Hu Y, Chen Z. Body mass index and chronic obstructive pulmonary diseaserelated mortality: a nationally representative prospective study of 220, 000 men in China. Int J Epidemiol 39:1027-1036, 2010.
210. Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care 56:644-652, 2011.
211. Yoneda T, Yoshikawa M, Fu A, Tsukaguchi K, Okamoto Y, Takenaka H. Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. Nutrition 17:95-99, 2001. (Pubitemid 32178284)
212. Yun Z, Lin Q, Giaccia AJ. Adaptive myogenesis under hypoxia. Mol Cell Biol 25:3040-3055, 2005. (Pubitemid 40464308)
213. Zhang J, Liu Y, Shi J, Larson DF, Watson RR. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med 227:823-829, 2002.